N

Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538

Watchlist Manager
Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538
Watchlist
Price: 13.09 CNY -5.56% Market Closed
Market Cap: 2.8B CNY
Have any thoughts about
Ningbo Menovo Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Ningbo Menovo Pharmaceutical Co Ltd stock under the Base Case scenario is 12.45 CNY. Compared to the current market price of 13.09 CNY, Ningbo Menovo Pharmaceutical Co Ltd is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
12.45 CNY
Overvaluation 5%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation Backtest
Ningbo Menovo Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Ningbo Menovo Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Ningbo Menovo Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Ningbo Menovo Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Ningbo Menovo Pharmaceutical Co Ltd.

What unique competitive advantages
does Ningbo Menovo Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Ningbo Menovo Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide P/S
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide P/E
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide P/OCF
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide P/FCFE
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide P/B
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide EV/S
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide EV/GP
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide EV/EBIT
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide EV/OCF
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide EV/FCFF
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide EV/IC
for Ningbo Menovo Pharmaceutical Co Ltd.

Show me price targets
for Ningbo Menovo Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Ningbo Menovo Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Ningbo Menovo Pharmaceutical Co Ltd?

What are the Net Income projections
for Ningbo Menovo Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Ningbo Menovo Pharmaceutical Co Ltd?

What are the EPS projections
for Ningbo Menovo Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Ningbo Menovo Pharmaceutical Co Ltd?

What are the EBIT projections
for Ningbo Menovo Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Ningbo Menovo Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Ningbo Menovo Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ningbo Menovo Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ningbo Menovo Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ningbo Menovo Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Ningbo Menovo Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Ningbo Menovo Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Ningbo Menovo Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide ROE
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide ROA
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide ROIC
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide ROCE
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide Gross Margin
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide Operating Margin
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide Net Margin
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide FCF Margin
for Ningbo Menovo Pharmaceutical Co Ltd.

Show all solvency ratios
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide D/E Ratio
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide D/A Ratio
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide Quick Ratio
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide Current Ratio
for Ningbo Menovo Pharmaceutical Co Ltd.

Provide Cash Ratio
for Ningbo Menovo Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Ningbo Menovo Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Ningbo Menovo Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Ningbo Menovo Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ningbo Menovo Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ningbo Menovo Pharmaceutical Co Ltd

Current Assets 1.9B
Cash & Short-Term Investments 671.5m
Receivables 387.8m
Other Current Assets 849.7m
Non-Current Assets 2.6B
Long-Term Investments 429.8m
PP&E 1.9B
Intangibles 210.6m
Other Non-Current Assets 63.1m
Current Liabilities 1.5B
Accounts Payable 371.2m
Accrued Liabilities 52.3m
Short-Term Debt 777.1m
Other Current Liabilities 334.2m
Non-Current Liabilities 885.9m
Long-Term Debt 696.5m
Other Non-Current Liabilities 189.4m
Efficiency

Earnings Waterfall
Ningbo Menovo Pharmaceutical Co Ltd

Revenue
1.2B CNY
Cost of Revenue
-879.9m CNY
Gross Profit
362.3m CNY
Operating Expenses
-330.2m CNY
Operating Income
32m CNY
Other Expenses
-32.4m CNY
Net Income
-326.3k CNY

Free Cash Flow Analysis
Ningbo Menovo Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Ningbo Menovo Pharmaceutical Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 1-Year Revenue Growth
Negative Net Income
Positive Operating Income
44/100
Profitability
Score

Ningbo Menovo Pharmaceutical Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Ningbo Menovo Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
50/100
Solvency
Score

Ningbo Menovo Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Ningbo Menovo Pharmaceutical Co Ltd

Wall Street analysts forecast Ningbo Menovo Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ningbo Menovo Pharmaceutical Co Ltd is 21.49 CNY with a low forecast of 21.28 CNY and a high forecast of 22.13 CNY.

Lowest
Price Target
21.28 CNY
63% Upside
Average
Price Target
21.49 CNY
64% Upside
Highest
Price Target
22.13 CNY
69% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Ningbo Menovo Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Ningbo Menovo Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Ningbo Menovo Pharmaceutical Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

2.9B CNY

Dividend Yield

0%

Description

Ningbo Menovo Pharmaceutical Co., Ltd. engages in the research, development, testing, production, and sale of pharmaceutical products. The company is headquartered in Ningbo, Zhejiang and currently employs 2,473 full-time employees. The company went IPO on 2017-04-07. The Company’s products contain gastropathic medicine and cardiovascular medicine, which include anti-hypertension medicine, anti-hyperlipidemia medicine and anti-thrombus medicine. The firm distributes its products to both domestic and overseas markets.

Contact

ZHEJIANG
Ningbo
Room 1406, No. 1, Lane 999, Yangfan Road, High-tech Zone
+8657487916065
www.menovopharm.com

IPO

2017-04-07

Employees

2 473

Officers

GM & Chairman
Mr. Cheng Zhi Yao
Director, CFO & Board Secretary
Mr. Gaofeng Ying
Deputy General Manager
Mr. Jian Xu

See Also

Discover More
What is the Intrinsic Value of one Ningbo Menovo Pharmaceutical Co Ltd stock?

The intrinsic value of one Ningbo Menovo Pharmaceutical Co Ltd stock under the Base Case scenario is 12.45 CNY.

Is Ningbo Menovo Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 13.09 CNY, Ningbo Menovo Pharmaceutical Co Ltd is Overvalued by 5%.

Back to Top